首页> 外文期刊>Hematological oncology >Cutaneous manifestations of hematologic malignancies the experience of an Italian dermatology department
【24h】

Cutaneous manifestations of hematologic malignancies the experience of an Italian dermatology department

机译:意大利皮肤病学部门的皮肤表现出意大利皮肤科的经验

获取原文
获取原文并翻译 | 示例
           

摘要

In recent years, dermatologic manifestations in oncohematologic patients have become more common. The aim of our study was to determine the incidence and heterogeneity of skin manifestations in patients followed at our Hematology Department. This observational monocentrical study was conducted on 60 patients. We divided the observed conditions in exanthematous, purpuric, vesicular-bullous, papulonodular, urticarial, and eczematous manifestations. Moreover, all lesions were classified according to pathogenesis, in (a) specific skin manifestations, caused by neoplastic skin infiltration; (b) immune-mediated manifestations, based on immunological mechanisms; and (c) skin lesions due to immunodeficiency. Altogether, 73 clinical manifestations were reported. Specific manifestations (a) were detected in 15.1% of the cases, mainly with papulonodular appearance. Immune-mediated manifestations (b) were found in 37 cases (50.7%), particularly with eczematous or exanthematous appearance, and leukemia was the malignancy most frequently reported in these patients. Eventually, lesions due to immunosuppression (c) were reported in 34.2% of the cases. They were represented by infections and cutaneous malignancies, and usually manifested with papulonodular lesions. Skin lesions in oncohematologic patients are a common event. A multidisciplinary approach based on the collaboration between the hematologist and the dermatologist is crucial to achieve a proper diagnosis, and correctly manage these manifestations.
机译:近年来,在加碘患者中皮肤病表现变得更加常见。我们的研究目的是确定在我们的血液学部门遵循患者皮肤表现的发病率和异质性。这种观察性单眼性研究是在60名患者进行的。我们将观察到的菌根,紫癜,细胞,幼儿阴性,荨麻疹和湿疹表现划分。此外,所有病变根据发病机制,(a)特异性皮肤表现,由肿瘤皮肤浸润引起的疾病; (b)根据免疫机制的免疫介导的表现; (c)由于免疫缺陷引起的皮肤病因。共报告了73个临床表现。在15.1%的病例中检测到特异性表现(a),主要是椎管胚胎外观。免疫介导的表现(b)在37例(50.7%)中发现(50.7%),特别是湿透或蛋白外观,白血病是这些患者最常报告的恶性肿瘤。最终,在34.2%的病例中报告了由于免疫抑制(c)引起的病变。它们是由感染和皮肤恶性肿瘤代表的,通常表现出苦瓜胚胎病变。 onCohematologic患者的皮肤病变是一个常见的事件。基于血液学学和皮肤科医生之间的合作的多学科方法至关重要,以实现适当的诊断,并正确管理这些表现形式。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号